14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $7.97 $9.98 Thursday, 2nd May 2024 ZYME stock ended at $9.00. This is 2.74% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 6.71% from a day low at $8.65 to a day high of $9.23.
90 days $7.97 $13.14
52 weeks $6.02 $13.14

Historical Zymeworks Inc prices

Date Open High Low Close Volume
Aug 21, 2023 $7.41 $7.67 $7.38 $7.65 322 903
Aug 18, 2023 $7.24 $7.46 $7.20 $7.42 283 599
Aug 17, 2023 $7.27 $7.37 $7.17 $7.35 360 585
Aug 16, 2023 $7.37 $7.42 $7.21 $7.27 217 008
Aug 15, 2023 $7.47 $7.57 $7.38 $7.42 264 149
Aug 14, 2023 $7.13 $7.50 $7.01 $7.49 421 663
Aug 11, 2023 $7.00 $7.73 $6.61 $7.17 861 673
Aug 10, 2023 $7.67 $7.94 $7.62 $7.76 649 850
Aug 09, 2023 $7.29 $7.73 $7.29 $7.70 514 001
Aug 08, 2023 $7.23 $7.46 $7.18 $7.29 383 955
Aug 07, 2023 $7.38 $7.42 $7.09 $7.26 430 765
Aug 04, 2023 $7.31 $7.62 $7.27 $7.39 370 135
Aug 03, 2023 $7.40 $7.55 $7.24 $7.32 388 780
Aug 02, 2023 $7.35 $7.53 $7.17 $7.32 406 252
Aug 01, 2023 $7.47 $7.53 $7.34 $7.45 350 973
Jul 31, 2023 $7.29 $7.59 $7.29 $7.46 512 859
Jul 28, 2023 $7.30 $7.40 $7.25 $7.27 309 522
Jul 27, 2023 $7.59 $7.66 $7.24 $7.28 436 454
Jul 26, 2023 $7.42 $7.55 $7.34 $7.51 464 538
Jul 25, 2023 $7.39 $7.67 $7.37 $7.45 473 045
Jul 24, 2023 $7.79 $7.80 $7.25 $7.39 602 699
Jul 21, 2023 $7.83 $7.93 $7.72 $7.87 632 076
Jul 20, 2023 $7.89 $7.90 $7.65 $7.77 332 606
Jul 19, 2023 $7.89 $8.06 $7.83 $7.87 482 403
Jul 18, 2023 $7.95 $8.05 $7.85 $7.86 349 854
Click to get the best stock tips daily for free!

About Zymeworks Inc

Zymeworks Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 ... ZYME Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT